After Initial Rejection, Indian Patent Office Grants Gilead Sciences Patent on Base Compound of Sofosbuvir Hepatitis C Drug

May 10 16
Take a look inside a Doctors Without Borders/Médecins Sans Frontières (MSF) project in South Sudan focused on kala azar, a neglected disease that is fatal if not treated; despite the fact that it kills some 50,000 people globally each year, according to the World Health Organization, treatment options are limited by the scarcity of affordable drugs and effective diagnostics.